AI Medical Compendium Journal:
Pharmacoepidemiology and drug safety

Showing 1 to 10 of 17 articles

Identifying inpatient mortality in MarketScan claims data using machine learning.

Pharmacoepidemiology and drug safety
PURPOSE: Inpatient mortality is an important variable in epidemiology studies using claims data. In 2016, MarketScan data began obscuring specific hospital discharge status types for patient privacy, including inpatient deaths, by setting the values ...

Performance of an automated deep learning algorithm to identify hepatic steatosis within noncontrast computed tomography scans among people with and without HIV.

Pharmacoepidemiology and drug safety
PURPOSE: Hepatic steatosis (fatty liver disease) affects 25% of the world's population, particularly people with HIV (PWH). Pharmacoepidemiologic studies to identify medications associated with steatosis have not been conducted because methods to eva...

Adverse events in the digital age and where to find them.

Pharmacoepidemiology and drug safety
Exponential growth of health-related data collected by digital tools is a reality within pharmaceutical and medical device research and development. Data generated through digital tools may be categorized as relevant to efficacy and/or safety. The en...

Machine learning for improving high-dimensional proxy confounder adjustment in healthcare database studies: An overview of the current literature.

Pharmacoepidemiology and drug safety
PURPOSE: Supplementing investigator-specified variables with large numbers of empirically identified features that collectively serve as 'proxies' for unspecified or unmeasured factors can often improve confounding control in studies utilizing admini...

Comparing LASSO and random forest models for predicting neurological dysfunction among fluoroquinolone users.

Pharmacoepidemiology and drug safety
BACKGROUND: Fluoroquinolones are associated with central (CNS) and peripheral (PNS) nervous system symptoms, and predicting the risk of these outcomes may have important clinical implications. Both LASSO and random forest are appealing modeling metho...

Predicting obesity and smoking using medication data: A machine-learning approach.

Pharmacoepidemiology and drug safety
PURPOSE: Administrative health datasets are widely used in public health research but often lack information about common confounders. We aimed to develop and validate machine learning (ML)-based models using medication data from Australia's Pharmace...

Machine learning outcome regression improves doubly robust estimation of average causal effects.

Pharmacoepidemiology and drug safety
BACKGROUND: Doubly robust estimation produces an unbiased estimator for the average treatment effect unless both propensity score (PS) and outcome models are incorrectly specified. Studies have shown that the doubly robust estimator is subject to mor...

Identifying drugs with disease-modifying potential in Parkinson's disease using artificial intelligence and pharmacoepidemiology.

Pharmacoepidemiology and drug safety
PURPOSE: The aim of the study was to assess the feasibility of an approach combining computational methods and pharmacoepidemiology to identify potentially disease-modifying drugs in Parkinson's disease (PD).

The use of natural language processing to identify vaccine-related anaphylaxis at five health care systems in the Vaccine Safety Datalink.

Pharmacoepidemiology and drug safety
PURPOSE: The objective was to develop a natural language processing (NLP) algorithm to identify vaccine-related anaphylaxis from plain-text clinical notes, and to implement the algorithm at five health care systems in the Vaccine Safety Datalink.

Comparison of text processing methods in social media-based signal detection.

Pharmacoepidemiology and drug safety
PURPOSE: Adverse event (AE) identification in social media (SM) can be performed using various types of natural language processing (NLP) and machine learning (ML). These methods can be categorized by complexity and precision level. Co-occurrence-bas...